Vestar Executives
ActiveNew York, NYBiotechnology, Investment Management, HealthcareLast fund filed December 2017
14 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| VESTAR EXECUTIVES VII | December 2017 | $50M | $26M | 70 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
14 partners are named across this firm’s filings, 14 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Daniel O'connell | Selective | None listed | 10 | 3 |
| Brian O'Connor | Slowing | Climate & energy, E-commerce & marketplaces, Food & agriculture | 6 | 1 |
| John Stephens | Slowing | Digital health, Enterprise software, Legal & compliance tech | 4 | 1 |
| Robert Rosner | Slowing | None listed | 4 | 1 |
| Brendan Spillane | Quiet | None listed | 0 | 0 |
| Chris Durbin | Quiet | Healthcare services | 1 | 0 |
| James Elrod, Jr. | Quiet | Healthcare services | 2 | 0 |
| James Kelley | Quiet | Digital health, Food & agriculture | 4 | 0 |
| Kenneth O'keefe | Quiet | None listed | 0 | 0 |
| Kevin Mundt | Quiet | Food & agriculture | 1 | 0 |
| Michelle Bergman | Quiet | None listed | 0 | 0 |
| Norman Alpert | Quiet | Healthcare services, Biotech & pharma | 3 | 0 |
| Roger Holstein | Quiet | Healthcare services | 1 | 0 |
| Steven Della Rocca | Quiet | Biotech & pharma | 1 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
Classified sectors of Vestar Executives’s own portfolio companies, based on 22 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Vestar Executives’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Battery Ventures | 2 | CH4 Power, Proteum Energy |
| Bridge Street | 1 | H-Food Holdings |
| Danish Energy Investors | 1 | H-Food Holdings |
| MBD | 1 | H-Food Holdings |
A shared board seat: a company where filings name a Vestar Executives partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.